State Key Laboratory of Oncogenes and Related Genes

State Key Laboratory of Oncogenes & Related Genes(SKLORG), affiliated to Shanghai Cancer Institute and ShanghaiJiaotong University, was founded in 1985 and approved to functionin 1987.

The laboratory currently has 52 faculty and staffs, including 35scientists (18 senior researchers). Meanwhile, the laboratoryoccupies 5300 square meters and is well equipped with 13 pieces ofinstruments valued more than 200 thousand RMB. At present, theState Key Laboratory consists of seven research sections:Functional Genomics; Tumor Invasion and Metastasis; Epigenetics; Molecular Pathology; Gene Therapy; SignalTransduction; Systems Biology.Based on the principles of systemsbiology and approaches of genomics, proteomics, metabonomics andmolecular cell biology, the research projects in SKLORG are mainlyfocused on: (1) identifying novel genes related to hepatocellularcarcinoma; (2) elucidating the mechanisms of hepatocarcinogenesisand liver cancer metastasis; (3) developing the novel methods forearly diagnosis and prevention. In the recent years, SKLORG won 30research grants, got 61 China Patents as well as 15 academicawards. In the mean time, the laboratory has published more than360 scientific papers, and trained 42 postgraduates for Ph. D.degree and 65 for master’s degree.

Address:

Cancer Institute of Shanghai Jiao Tong University,25/Ln2200 Xie-Tu Road,Shanghai 200032 P.R.China

www.shsci.org

Director:

WangHongyang

Title:

Professor,Distinguished professor for “Chang JiangScholars”,academician of Chinese Academy ofEngineering

AcademicBackground:

Professor Wang set up the International Co-operationLaboratory on Signal Transduction in Shanghai Eastern HepatobiliarySurgery Institute/Hospital and established a clinical treatmentdistrict after she came back from Germany in 1997, forming aninnovative research unit that combines basic and clinical research.Professor Wang has published more than 90 papers on high-impactedjournals such as J.E.M., Gastroenterology , Hepatology, CancerRes., Nature、 Oncogene and, J.B.C.,with a total impact factor of230.

ResearchInterest:

molecularpathological mechanism of tumorigenesis and tumor development,signal transduction and network regulation of tumor and livercancer molecular biomarker screening

Awards:

ProfessorWang has received the prize of national natural science award(Grade II), scientific and technological advancement award of HeLiang He Li foundation, the prize of scientific and technologicaladvancement award of PLA (Grade I), and prize of Shanghai medicalscientific and technological award (Grade I). She is the winner of“Science and Technology Elite of Shanghai” and “Golden Star ofScience and Technology” awarded by General LogisticsDepartment.

Publications:

1.Use ofadenovirus-delivered siRNA to target oncoprotein p28GANK inhepatocellular carcinoma.Li H, Fu X, Chen Y, Hong Y, Tan Y, Cao H,Wu M,WangH.Gastroenterology.2005Jun;128(7):202941.

2.LPS-induced down-regulation of signal regulatoryprotein {alpha} contributes to innate immune activation inmacrophages.Kong XN, Yan HX, Chen L, Dong LW, Yang W, Liu Q, Yu LX,Huang DD, Liu SQ, Liu H, Wu MC, Wang HY.J Exp Med. 2007 Oct29;204(11):2719-31. Epub 2007 Oct22.

3.Negativeregulation of hepatocellular carcinoma cell growth by signalregulatory protein alpha1.Yan HX, Wang HY, Zhang R, Chen L, Li BA,Liu SQ, Cao HF, Qiu XH, Shan YF, Yan ZH, Wu HP, Tan YX, WuMC.

Hepatology. 2004 Sep;40(3):618-28.

Tel:

86-21-25070856

Email:

hywangk@vip.sina.com

上海交大医学院英文站
 
 
进入编辑状态